BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18194413)

  • 1. Prevalence of post-thrombotic syndrome following asymptomatic thrombosis in survivors of acute lymphoblastic leukemia.
    Kuhle S; Spavor M; Massicotte P; Halton J; Cherrick I; Dix D; Mahoney D; Bauman M; Desai S; Mitchell LG
    J Thromb Haemost; 2008 Apr; 6(4):589-94. PubMed ID: 18194413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study.
    Mitchell LG; Andrew M; Hanna K; Abshire T; Halton J; Anderson R; Cherrick I; Desai S; Mahoney D; McCuster P; Wu J; Dahl G; Chait P; de Veber G; Lee KJ; Mikulis D; Ginsberg J; Way C;
    Cancer; 2003 Jan; 97(2):508-16. PubMed ID: 12518376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of venography and ultrasound for the diagnosis of asymptomatic deep vein thrombosis in the upper body in children: results of the PARKAA study. Prophylactic Antithrombin Replacement in Kids with ALL treated with Asparaginase.
    Male C; Chait P; Ginsberg JS; Hanna K; Andrew M; Halton J; Anderson R; McCusker P; Wu J; Abshire T; Cherrick I; Mahoney D; Mitchell L
    Thromb Haemost; 2002 Apr; 87(4):593-8. PubMed ID: 12008940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l-asparaginase for acute lymphoblastic leukemia. Results of the PAARKA study.
    Mitchell L; Andrew M; Hanna K; Abshire T; Halton J; Wu J; Anderson R; Cherrick I; Desai S; Mahoney D; McCusker P; Chait P; Abdolell M; de Veber G; Mikulis D
    Thromb Haemost; 2003 Aug; 90(2):235-44. PubMed ID: 12888870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic effects of asparaginase in two acute lymphoblastic leukemia protocols (NOPHO ALL-1992 versus NOPHO ALL-2000): a single-institution study.
    Ruud E; Holmstrøm H; de Lange C; Natvig S; Albertsen BK; Wesenberg F
    Pediatr Hematol Oncol; 2006; 23(3):207-16. PubMed ID: 16517537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombin deficiency after prolonged asparaginase treatment in children with acute lymphoblastic leukemia.
    Ranta S; Heyman MM; Jahnukainen K; Taskinen M; Saarinen-Pihkala UM; Frisk T; Söderhäll S; Petrini P; Mäkipernaa AM
    Blood Coagul Fibrinolysis; 2013 Oct; 24(7):749-56. PubMed ID: 24056293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-thrombotic syndrome after central venous catheter removal in childhood cancer survivors is associated with a history of obstruction.
    Revel-Vilk S; Menahem M; Stoffer C; Weintraub M
    Pediatr Blood Cancer; 2010 Jul; 55(1):153-6. PubMed ID: 20232430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-thrombotic syndrome after central venous catheter removal in childhood cancer survivors: A prospective cohort study.
    Polen E; Weintraub M; Stoffer C; Jaffe DH; Burger A; Revel-Vilk S
    Pediatr Blood Cancer; 2015 Feb; 62(2):285-290. PubMed ID: 25359689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and risk factors for post thrombotic syndrome after deep vein thrombosis in children: a cohort study.
    Kumar R; Rodriguez V; Matsumoto JM; Khan SP; Weaver AL; McBane RD; Beebe TJ; Heit JA
    Thromb Res; 2015 Feb; 135(2):347-51. PubMed ID: 25528070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of prognostic factors and prevalence of post-thrombotic syndrome in patients with deep vein thrombosis in Spain].
    Ordi J; Salmerón L; Acosta F; Camacho I; Marín N;
    Med Clin (Barc); 2016 Jan; 146(2):49-54. PubMed ID: 26198362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute prognostic factors for post-thrombotic syndrome in children with limb DVT: a bi-institutional cohort study.
    Lyle CA; Gibson E; Lovejoy AE; Goldenberg NA
    Thromb Res; 2013 Jan; 131(1):37-41. PubMed ID: 23195142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a clinical prediction model for the postthrombotic syndrome in a prospective cohort of patients with proximal deep vein thrombosis.
    Rabinovich A; Ducruet T; Kahn SR;
    J Thromb Haemost; 2018 Feb; 16(2):262-270. PubMed ID: 29193770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compression therapy for prevention of post-thrombotic syndrome.
    Appelen D; van Loo E; Prins MH; Neumann MH; Kolbach DN
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD004174. PubMed ID: 28950030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and cost burden of post-thrombotic syndrome.
    Ashrani AA; Heit JA
    J Thromb Thrombolysis; 2009 Nov; 28(4):465-76. PubMed ID: 19224134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 3 Postthrombotic Syndrome Assessment Scales Demonstrates Significant Variability in Children and Adolescents With Deep Vein Thrombosis.
    Raffini L; Davenport J; Bevilacqua L; Iosifescu S
    J Pediatr Hematol Oncol; 2015 Nov; 37(8):611-5. PubMed ID: 26207775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and Risk Factors for Post-Thrombotic Syndrome in Patients With Deep Vein Thrombosis Following Total Knee and Hip Arthroplasty.
    Zhang Z; Song K; Yao Y; Jiang T; Pan P; Jiang Q
    J Arthroplasty; 2019 Mar; 34(3):560-563. PubMed ID: 30503320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for post-thrombotic syndrome in patients with a first deep venous thrombosis.
    Tick LW; Kramer MH; Rosendaal FR; Faber WR; Doggen CJ
    J Thromb Haemost; 2008 Dec; 6(12):2075-81. PubMed ID: 18983518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolytic strategies versus standard anticoagulation for acute deep vein thrombosis of the lower limb.
    Broderick C; Watson L; Armon MP
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD002783. PubMed ID: 33464575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic events revisited in children with acute lymphoblastic leukemia: impact of concomitant Escherichia coli asparaginase/prednisone administration.
    Nowak-Göttl U; Heinecke A; von Kries R; Nürnberger W; Münchow N; Junker R
    Thromb Res; 2001 Aug; 103(3):165-72. PubMed ID: 11672578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombin supplementation III in childhood acute lymphoblastic leukemia treated with L-asparaginase.
    Matsuzaki A; Suminoe A; Hara T
    Pediatr Hematol Oncol; 2002 Dec; 19(8):601-3. PubMed ID: 12487838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.